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Abstract
Aim:  To investigate the cancer risk among residents of Rhineland-Palatinate winegrowing
communities in an ecological study.
Methods: On the basis of the Rhineland-Palatinate cancer-registry, we calculated age-adjusted
incidence rate ratios for communities with a medium area under wine cultivation (>5 to 20
percent) and a large area under wine cultivation (>20 percent) in comparison with communities
with a small area under wine cultivation (>0 to 5 percent). In a side analysis, standardized cancer
incidence ratios (SIR) were computed separately for winegrowing communities with small, medium
and large area under wine cultivation using estimated German incidence rates as reference.
Results:  A statistically significant positive association with the extent of viniculture can be
observed for non-melanoma skin cancer in both males and females, and additionally for prostate
cancer, bladder cancer, and non-Hodgkin lymphoma in males, but not in females. Lung cancer risk
is significantly reduced in communities with a large area under cultivation. In the side-analysis,
elevated SIR for endocrine-related tumors of the breast, testis, prostate, and endometrium were
observed.
Conclusion: This study points to a potentially increased risk of skin cancer, bladder cancer, and
endocrine-mediated tumors in Rhineland-Palatinate winegrowing communities. However, due to
the explorative ecologic study design and the problem of multiple testing, these findings are not
conclusve for a causal relationship.
Introduction
Some previous studies point to a potential association
between pesticide exposure resp. farming or winegrowing
and lymphoma [1-5] or multiple myeloma [6-11], brain
cancer [12-14], prostate cancer [15], or bladder cancer
[16,17]. However, the mechanisms of the suspected carci-
nogenic effects of pesticides are widely unclear.
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Among the hypothesis on potential carcinogenic mecha-
nisms from pesticides, the endocrine mediated effects
have received much attention. Several pesticides interact
with endocrine receptors in vitro or have endocrine-medi-
ated effects in laboratory animals in vivo: The European
Union has listed over 40 pesticides suspected to interfere
with the hormone system of humans and wildlife [18]. As
endocrine-related mechanisms play an etiologic role in
several cancers in humans, the potential association
between exposure to pesticides with endocrine activity
and cancer incidence has been discussed in the last years.
Many epidemiological studies have, for example, exam-
ined the relationship between pesticides and breast cancer
[19]. However, although endogenous and exogenous
estrogens are known to play a causal role in the aetiology
of breast cancer, the to date epidemiological and experi-
mental evidence is not conclusive for an association
between exposure to organochlorine pesticides and breast
cancer incidence (for an overview, see [19]). According to
Barlow [19], the evidence on other endocrine-related
tumour sites (testes, prostate, endometrium) is too sparse
to draw any conclusions concerning pesticides.
Rhineland-Palatinate is the federal state with the most
extensive winegrowing in Germany: About 3 percent of
the Rhineland-Palatinate area is under wine cultivation.
Therefore, a potential pesticide exposure of the residential
population might be assumed. Actual deposit measure-
ments in one Rhineland-Palatinate wine district (Moselle
region) point to an ongoing insecticide (parathione) and
herbicide (atrazine, simazine) exposure of the residential
population [20]. Repeatedly, a suspected increase in can-
cer incidence has been a subject of concern in the men-
tioned region. The aim of the present ecological study is
therefore to investigate the cancer risk among residents of
Rhineland-Palatinate winegrowing communities com-
pared to the cancer risk among residents of communities
with a small area under wine cultivation.
Materials and methods
Study population and study area
Each Rhineland-Palatinate winegrowing community (n =
503, out of 2,305 communities in Rhineland-Palatinate)
was categorized according to the proportion of area under
wine cultivation of the whole community area (small: >0
to 5 percent; medium: >5 to 20 percent; large: >20 percent
area under wine cultivation; see Table 1) based on official
data for 1996. 1.3 percent of the total area of communities
with a small area under cultivation is area under wine,
respectively, 12.5 percent of the total area of communities
with a medium area under cultivation, and 31.4 percent of
the total area of communities with a large area under cul-
tivation. Table 1 gives some characteristics of the Rhine-
land-Palatinate study region.
Cancer registry data
This study is based on cancer cases registered in the Rhine-
land-Palatinate cancer registry which covers a population
of approximately 4,000,000 persons. We included all
malignant tumours plus benign brain and CNS tumours
and brain and CNS tumours of uncertain behaviour. Fur-
thermore, we included malignant bladder tumours plus
carcinoma in situ and tumours of uncertain behaviour of
the bladder. Since January 2000 all Rhineland-Palatinate
physicians and dentists are legally obliged to report inci-
dent cancer cases to the cancer registry. Therefore, all
above mentioned cancers diagnosed between 2000 and
2003 and reported until mid-2005 were included. The fol-
lowing items are registered: diagnosis (ICD-10); topogra-
phy and morphology (ICD-O-2); staging (TNM);
incidence date; most valid basis of diagnosis; occasion of
first detection; initial treatment; last occupation and long-
est held occupation; and date and cause of death (where
appropriate). Population figures and data on area under
wine cultivation were obtained from the statistical office
of Rhineland-Palatinate.
Statistical methods
Completeness of the Rhineland-Palatinate cancer registry
varies with time, region, physician's specialization and
type of cancer. This had to be considered in our analysis.
Completeness is estimated by the ratio of reported cases to
estimated cases for Rhineland-Palatinate calculated from
a national pooling of cancer registry data [21,22]. In com-
munities with a small area under wine cultivation, the
completeness (excluding non-melanotic skin cancer) is
Table 1: Characteristics of the Rhineland-Palatinate vineyard area
Rhineland-Palatinate* Area under wine (% of community area)
Total > 0%, ≤ 5% >5%, ≤ 20% >20%
Communities 2,305 162 171 170
Total area (ha) 1,984,688 222,736 200,709 129,444
Area under wine (ha) 69,043 2,996 25,101 40,683
% area under wine 3.5% 1.3% 12.5% 31.4%
Inhabitants (per ha) 4,000,567 (2.02) 564,210 (2.53) 526,486 (2.62) 301,193 (2.33)
Inhabitants per community (median, min-max) 566 (6–184,752) 1,188 (72–99,750) 1,193 (95–80,535) 984 (84–40,110)
* All data pertain to Dec 31st, 1996 (Statistisches Landesamt Rheinland-Pfalz 2006)Journal of Occupational Medicine and Toxicology 2008, 3:12 http://www.occup-med.com/content/3/1/12
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Table 2: Cancer risks (incidence rate ratios RR) in men with residence in communities with a large or medium area under wine 
cultivation vs. men in communities with low area under wine cultivation
Reference* 
(1,665,594 PY†)
Area under wine cultivation > 5, ≤ 
20% of community area (1,039,435 
PY†)
Area under wine cultivation > 20% 
of community area (612,714 PY†)
ICD-10 code Cases Cases RR‡§ 95% CI Cases RR‡§ 95% CI
Head & neck (C00–C14) 369 188 0.91 0.72–1.15 94 0.86 0.65–1.14
Base of tongue (C01) 35 11 0.53 0.26–1.08 10 0.87 0.40–1.91
Other and unspecified parts of tongue (C02) 35 26 1.22 0.72–2.07 13 1.12 0.56–2.25
Floor of mouth (C04) 42 25 0.98 0.57–1.70 11 0.70 0.34–1.47
Palate (C05) 22 15 1.24 0.62–2.49 5 0.88 0.31–2.54
Other and unspecified parts of mouth (C06) 18 8 0.71 0.29–1.73 3 0.45 0.12–1.71
Parotid gland (C07) 14 8 0.92 0.36–2.30 4 0.80 0.24–2.67
Tonsil (C09) 47 22 0.78 0.45–1.34 13 0.79 0.40–1.56
Oropharynx (C10) 35 15 0.78 0.39–1.57 5 0.48 0.17–1.34
Piriform sinus (C12) 20 10 0.90 0.41–2.02 8 1.67 0.66–4.25
Hypopharynx (C13) 56 27 0.76 0.46–1.26 17 0.88 0.48–1.62
Oesophagus (C15) 156 94 0.96 0.73–1.27 42 0.82 0.57–1.20
Stomach (C16) 241 166 1.06 0.86–1.31 92 1.03 0.79–1.34
Small intestine (C17) 24 14 0.92 0.45–1.86 2 0.21 0.05–0.95
Colon, sigmoid & rectum (C18–C21) 1188 806 1.07 0.95–1.21 460 1.10 0.96–1.26
Colon (C18) 723 473 1.04 0.91–1.20 268 1.06 0.90–1.25
Rectosigmoid junction (C19) 51 42 1.33 0.89–2.00 30 1.68 1.04–2.71
Rectum (C20) 397 284 1.13 0.94–1.35 157 1.10 0.89–1.37
Anus and anal canal (C21) 17 7 0.66 0.26–1.64 5 0.85 0.29–2.50
Liver and intrahepatic bile ducts (C22) 141 73 0.94 0.68–1.30 37 0.88 0.58–1.32
Gallbladder & biliary tract (C23–C24) 76 33 0.67 0.44–1.02 27 0.95 0.59–1.54
Gallbladder (C23) 17 7 0.58 0.23–1.46 7 0.96 0.36–2.53
Other and unspecified parts of biliary tract (C24) 59 26 0.70 0.43–1.13 20 0.95 0.55–1.65
Pancreas (C25) 162 99 1.03 0.78–1.36 51 0.96 0.68–1.37
Nasal cavity and middle ear (C30–C31) 18 9 0.73 0.32–1.67 4 0.51 0.16–1.62
Larynx (C32) 135 78 0.94 0.68–1.29 39 0.88 0.59–1.31
Trachea, bronus and lung (C33–C34) 1039 530 0.98 0.84–1.14 232 0.77 0.64–0.92
Bronchus and lung (C34) 1036 530 0.98 0.84–1.15 232 0.77 0.64–0.92
Bone and articular cartilage (C40–C41) 11 7 0.88 0.32–2.42 3 0.49 0.13–1.89
Skin, malignant melanoma (C43) 230 188 1.32 1.08–1.60 119 1.50 1.18–1.91
Skin, other malignant neoplasms (C44) 1990 1748 1.32 1.20–1.45 959 1.39 1.25–1.54
Mesothelioma (C45) 19 12 1.09 0.52–2.28 5 0.92 0.32–2.68
Other connective and soft tissue (C49) 32 35 1.65 1.00–2.70 9 0.68 0.31–1.48
Breast (C50) 14 9 1.02 0.43–2.39 3 0.60 0.16–2.25
Penis (C60) 20 15 1.17 0.56–2.44 6 0.71 0.26–1.93
Prostate (C61) 1857 1359 1.26 1.12–1.41 787 1.26 1.11–1.43
Testis (C62) 154 107 1.18 0.88–1.60 77 1.31 0.94–1.83
Urinary tract (C64-C66+C68) 330 206 1.03 0.85–1.26 107 0.96 0.75–1.23
Kidney, except renal pelvis (C64) 269 171 1.06 0.86–1.32 89 1.00 0.76–1.31
Ureter (C66) 30 7 0.35 0.15–0.80 7 0.58 0.24–1.39
Bladder (C67, D09.0, D41.4) 699 470 1.16 1.01–1.34 266 1.31 1.10–1.55
Eye and adnexa (C69) 15 8 1.02 0.43–2.43 3 0.88 0.23–3.37
Meninges (C70) 22 20 1.45 0.78–2.69 7 0.88 0.35–2.18
Brain, CNS, meninges (C70–C72, D32–33, D42–
43)
133 90 1.08 0.81–1.44 53 1.04 0.73–1.49
Brain (C71, D33, D43) 109 70 1.02 0.74–1.41 45 1.06 0.72–1.57
Thyroid gland (C73) 33 23 1.11 0.64–1.92 16 1.31 0.68–2.53
Hodgkin's disease (C81) 40 24 0.86 0.51–1.46 12 0.64 0.32–1.27
Follicular NHL (C82) 29 21 1.23 0.67–2.25 19 1.98 1.01–3.85
NHL (C82–C85) 197 130 1.12 0.88–1.42 81 1.29 0.96–1.73
Diffuse NHL (C83) 122 66 0.91 0.66–1.24 31 0.80 0.52–1.23
Peripheral and cutaneous T-cell lymphomas (C84) 10 6 0.94 0.33–2.68 8 2.19 0.75–6.37
Other and unspecified types of NHL (C85) 36 37 1.64 1.03–2.59 23 1.84 1.05–3.23
Multiple myeloma (C90) 63 36 0.93 0.60–1.44 21 0.92 0.53–1.59
Leukaemia (C91–C95) 204 113 0.89 0.69–1.15 61 0.84 0.61–1.16
Lymphoid leukaemia (C91) 116 56 0.74 0.53–1.05 28 0.65 0.41–1.02Journal of Occupational Medicine and Toxicology 2008, 3:12 http://www.occup-med.com/content/3/1/12
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about 80 percent in males and 79 percent in females. Con-
cerning lymphohaematopoetic malignancies, the com-
pleteness is considerably lower; in communities with a
small area under cultivation, only 62 percent of Non-
Hodgkin lymphoma (NHL) in males and 64 percent in
females are reported to the registry.
Primary "internal" analysis of incidence ratio ratios for 
communities with a medium or large area under 
cultivation in comparison with communities with a small 
area under cultivation
To account for regional variations in completeness, in our
primary analysis communities with a small area under
wine cultivation served as reference. Provided that the
completeness does not differ systematically between
winegrowing communities with a large area under cultiva-
tion and adjoining communities with a small area under
cultivation, this allows to calculate valid incidence rate
ratios by Poisson regression.
Population figures are reported in five year age categories
by the State Statistical Office; due to small numbers, the
use of a categorized age variable would have caused
numerical problems in the regression analysis. Instead,
age was included as a continuous variable in the regres-
sion analysis (mid-point of each age category). Many fac-
tors, like sociodemographic, lifestyle and environmental
factors, might considerably differ between large cities and
villages/small cities. Cities with more than 100,000
inhabitants (Mainz, Ludwigshafen/Rhein, Koblenz, Kai-
serslautern) were therefore excluded from the analysis.
Furthermore, we adjusted for rural (<5,000 inhabitants)
vs. urban (≥ 5,000 inhabitants) communities. The propor-
tion of community area under fruit cultivation (another
potential source of pesticides exposure) was included in
the analyses as dichotomous confounder (<5 percent vs. ≥
5 percent of community area).
All analyses were preformed in SAS [23], stratified by gen-
der and cancer type. The regression analysis includes can-
cer rate as dependent variable, and age, wine growing area,
rural/urban setting and fruit cultivation. All analyses were
stratified by gender and diagnosis. The results of our ini-
tial Poisson regression indicated a possible problem with
overdispersion, which is partly due to heterogeneity
between communities with respect to unobserved risk fac-
tors. We therefore opted to assume a negative binomial
distribution for the dependent variable, which allows to
estimate a dispersion parameter k for the variance (vari-
ance = expected value·(1+k·expected value)) and
includes the Poisson distribution as a special case (k = 0).
The negative binomial distribution emerges naturally if
expected counts (Poisson parameters) vary among com-
munities according to a gamma distribution. The interpre-
tation of rate ratios stays the same as for Poisson
regression. However, results do not substantially differ.
For a few rare cancers, the ML fitting algorithm did not
converge using the negative binomial distribution. In
these cases, estimates from Poisson regression are
reported.
Side analysis of standardized incidence ratios (SIR) using 
German incidence rates as reference
Even in communities with a small area under cultivation,
cancer incidence might be elevated, potentially leading to
an underestimation of rate ratios in communities with
medium or large area under cultivation. In an additional
analysis, we therefore calculated standardized incidence
ratios (SIR) regardless of the incompleteness of the Rhine-
land-Palatinate cancer registry. Standardized cancer inci-
dence ratios were separately computed for winegrowing
communities with small, medium, and large area under
cultivation using estimated German incidence rates. The
expected numbers of cancer (E) for the time period 2000–
2003 were compared with the observed numbers (O), cal-
culating standardized incidence ratios (SIR) as the ratio
between the observed and expected numbers. Exact 95%-
confidence intervals (CI) based on the Poisson distribu-
tion of O were calculated.
Results of any analysis based on small numbers are diffi-
cult to interpret. Therefore, only those results based on at
least ten cases in the respective referent group and ten
cases in both comparison groups combined are reported
here.
Results
Tables 2 and 3 present incidence rate ratios (RR) for can-
cer in males and females for winegrowing communities
with medium (> 5 to ≤ 20 percent) and large (>20 per-
Myeloid leukaemia (C92) 77 52 1.09 0.75–1.59 27 0.99 0.61–1.60
Primary site unspecified 128 83 0.99 0.75–1.30 43 0.88 0.61–1.28
All malignancies (excluding C44) 7761 5024 1.12 1.05–1.19 2765 1.10 1.03–1.18
All malignancies (including C44) 9751 6772 1.15 1.09–1.22 3724 1.16 1.09–1.23
* Winegrowing communities with >0, <= 5% area under wine cultivation
† PY: Person-Years were approximated by population figures: the sum of population at the end of the year in the years under consideration.
‡ adjusted for age, rural or urban environment, and fruit cultivation
§ Poisson distribution of case counts assumed for: C45, C50, C70
Table 2: Cancer risks (incidence rate ratios RR) in men with residence in communities with a large or medium area under wine 
cultivation vs. men in communities with low area under wine cultivation (Continued)Journal of Occupational Medicine and Toxicology 2008, 3:12 http://www.occup-med.com/content/3/1/12
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Table 3: Cancer risks (incidence rate ratios RR) in women with residence in communities with a large or medium area under wine 
cultivation vs. women in communities with low area under wine cultivation
Reference* 
(1,778,184 PY†)
Area under wine cultivation > 5, ≤ 20% 
of community area (1,098,069 PY†)
Area under wine cultivation > 20% of 
community area (634,060 PY†)
ICD-10 code Cases Cases RR‡§ 95% CI Cases RR‡§ 95% CI
Head & neck (C00–C14) 123 70 1.05 0.74–1.50 41 1.14 0.75–1.74
Other and unspecified parts of tongue (C02) 14 8 1.01 0.41–2.48 6 1.56 0.52–4.64
Oropharynx (C10) 19 6 0.53 0.20–1.39 5 0.81 0.28–2.39
Oesophagus (C15) 38 17 0.89 0.46–1.70 9 0.91 0.40–2.08
Stomach (C16) 197 147 1.27 1.01–1.60 61 1.07 0.79–1.47
Small intestine (C17) 24 17 1.17 0.64–2.15 8 1.04 0.45–2.40
Colon, sigmoid & rectum (C18–C21) 1122 733 1.04 0.92–1.17 346 0.94 0.81–1.09
Colon (C18) 734 509 1.11 0.97–1.28 214 0.90 0.75–1.08
Rectosigmoid junction (C19) 64 32 0.78 0.51–1.21 20 0.86 0.50–1.48
Rectum (C20) 301 180 0.95 0.78–1.17 108 1.06 0.83–1.35
Anus and anal canal (C21) 23 12 0.89 0.44–1.81 4 0.60 0.20–1.83
Liver and intrahepatic bile ducts (C22) 43 32 1.17 0.72–1.90 19 1.20 0.66–2.19
Gallbladder & biliary tract (C23–C24) 79 58 1.13 0.79–1.61 19 0.64 0.38–1.09
Gallbladder (C23) 39 38 1.44 0.89–2.33 10 0.64 0.30–1.34
Other and unspecified parts of biliary tract 
(C24)
40 20 0.78 0.46–1.34 9 0.63 0.29–1.34
Pancreas (C25) 158 85 0.97 0.72–1.29 40 0.93 0.64–1.37
Larynx (C32) 19 12 0.99 0.47–2.07 4 0.56 0.18–1.75
Trachea, bronus and lung (C33–C34) 342 168 0.99 0.77–1.27 94 1.19 0.88–1.59
Bronchus and lung (C34) 340 167 0.99 0.77–1.27 94 1.19 0.89–1.60
Skin, malignant melanoma (C43) 274 212 1.17 0.96–1.42 109 1.00 0.78–1.28
Skin, other malignant neoplasms (C44) 1710 1620 1.40 1.27–1.54 807 1.38 1.23–1.53
Retroperitoneum and peritoneum (C48) 10 9 1.72 0.65–4.53 4 1.93 0.53–7.02
Other connective and soft tissue (C49) 30 17 0.98 0.54–1.79 9 1.03 0.46–2.32
Breast (C50) 2525 1527 1.08 0.98–1.20 779 1.01 0.90–1.12
Vulva (C51) 63 36 0.98 0.64–1.50 22 1.23 0.72–2.10
Vagina (C52) 18 20 1.80 0.94–3.45 5 0.82 0.29–2.33
Cervix uteri (C53) 162 97 1.03 0.79–1.34 47 0.94 0.66–1.34
Corpus uteri, (C54–C55) 382 244 1.15 0.94–1.41 146 1.20 0.95–1.52
Corpus uteri (C54) 370 232 1.13 0.92–1.39 144 1.22 0.97–1.54
Uterus, part unspecified (C55) 12 12 1.58 0.70–3.59 2 0.46 0.10–2.17
Ovary and other unspecified female genital 
organs (C56–C57)
297 196 1.09 0.89–1.34 96 0.97 0.75–1.26
Ovary (C56) 284 183 1.07 0.86–1.32 93 0.99 0.76–1.28
Other and unspecified female genital organs 
(C57)
13 13 1.66 0.76–3.63 3 0.73 0.19–2.72
Urinary tract (C64-C66+C68) 208 136 1.10 0.86–1.40 73 1.04 0.77–1.40
Kidney, except renal pelvis (C64) 166 116 1.14 0.88–1.48 63 1.09 0.79–1.50
Renal pelvis (C65) 24 10 0.71 0.33–1.49 4 0.55 0.18–1.71
Ureter (C66) 16 10 1.02 0.45–2.29 4 0.75 0.23–2.44
Bladder (C67, D09.0, D41.4) 251 158 1.09 0.88–1.34 85 1.19 0.90–1.56
Brain, CNS, meninges (C70–C72, D32–33, 
D42–43)
167 105 1.11 0.84–1.46 62 1.25 0.89–1.75
Meninges (C70) 57 46 1.33 0.87–2.03 24 1.29 0.75–2.21
Brain (C71, D33, D43) 107 57 0.98 0.68–1.40 37 1.21 0.79–1.86
Thyroid gland (C73) 102 75 1.20 0.86–1.67 32 0.86 0.56–1.34
Hodgkin's disease (C81) 39 20 0.83 0.48–1.44 9 0.64 0.29–1.39
NHL (C82–C85) 220 114 0.93 0.72–1.21 52 0.78 0.56–1.09
Follicular NHL (C82) 50 18 0.58 0.34–1.01 5 0.29 0.11–0.76
Diffuse NHL (C83) 106 69 1.05 0.76–1.45 25 0.73 0.46–1.17
Other and unspecified types of NHL (C85) 56 24 0.71 0.43–1.14 19 1.07 0.61–1.89
Multiple myeloma (C90) 68 30 0.72 0.46–1.13 21 0.88 0.51–1.49
Leukaemia (C91–C95) 135 65 0.80 0.59–1.09 43 0.98 0.68–1.43
Lymphoid leukaemia (C91) 67 33 0.78 0.51–1.18 22 0.90 0.54–1.50
Myeloid leukaemia (C92) 60 32 0.90 0.59–1.37 16 0.92 0.51–1.66Journal of Occupational Medicine and Toxicology 2008, 3:12 http://www.occup-med.com/content/3/1/12
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cent) area under cultivation compared to communities
with small (> 0 to ≤ 5 percent) area under cultivation. Sig-
nificantly increased RR are observed for non-melanoma
skin cancer (C44 ICD-10) among men (RR = 1.32 (95%
confidence interval CI 1.20–1.45) for medium and RR =
1.39 (95% CI 1.25–1.54) for a large area under cultiva-
tion) as well as among women (RR = 1.40 (95% CI 1.27–
1.54) for medium and RR = 1.38 (95% CI 1.23–1.53) for
a large area under cultivation).
Among men, the rate ratios for a large vs. a small area
under cultivation are significantly elevated for the follow-
ing malignancies: malignant melanoma (C43 ICD-10; RR
= 1.50; 95% CI 1.18–1.91), prostate cancer (C61 ICD-10:
RR = 1.26; 95% CI 1.11–1.43), bladder cancer (C67 ICD-
10; RR = 1.31; 95% CI 1.10–1.55), follicular NHL (C82
ICD-10; RR = 1.98; 95% CI 1.01–3.85) and other and
unspecified types of NHL (C85 ICD-10; RR = 1.84; 95%
CI 1.05–3.23). In contrast, we find significantly decreased
rate ratios for follicular NHL among women (RR = 0.29
(95% CI 0.11–0.76) for a large vs. a small area under cul-
tivation).
Furthermore rate ratios are significantly decreased among
men for lung cancer (C34 ICD-10; RR = 0.77; 95% CI
0.64–0.92 for a large vs. a small area under cultivation).
Both men and women showed a slightly elevated RR for
all malignancies for communities with medium (men: RR
= 1.15; 95% CI 1.09–1.22; women: RR = 1.14; 95% CI
1.08–1.21) as well as with a large area under cultivation
(men: RR = 1.16; 95% CI 1.09–1.23; women: RR = 1.10;
95% CI 1.04–1.17).
When non-melanotic skin cancer was excluded, among
men, risk ratios for all malignancies remained signifi-
cantly elevated in communities with medium and a large
area under cultivation; among women, solely rate ratios in
communities with a medium area under cultivation
retained significance.
Tables 4 and 5 present standardized incidence ratios (SIR)
for cancer in males and females for winegrowing commu-
nities with small (>0 to ≤ 5 percent), medium (> 5 to ≤ 20
percent) and large (>20 percent) area under cultivation
using estimated incidence of cancer in the national popu-
lation of Germany as reference. As the incompleteness of
Table 4: Cancer risks (standardized incidence ratios SIR) in men with residence in communities with planted winegrowing areas with 
the estimated incidence of cancer in the national population of Germany as reference
Area under wine cultivation > 0, ≤ 5% of 
community area (1,665,594 PY†)
Area under wine cultivation > 5, ≤ 20% of 
community area (1,039,435 PY†)
Area under wine cultivation > 20% of 
community area (612,714 PY†)
ICD-10 code Observed Expected SIR 95% CI Observed Expected SIR 95% CI Observed Expected SIR 95% CI
Head & neck (C00–C14) 369 238.00 1.13 1.01–1.25 188 205.94 0.91 0.79–1.05 94 117.54 0.80 0.65–0.98
Stomach (C16) 241 421.10 0.57 0.50–0.65 166 262.89 0.63 0.54–0.74 92 144.55 0.64 0.51–0.78
Colon, sigmoid & rectum 
(C18–C21)
1188 1445.33 0.82 0.78–0.87 806 906.16 0.89 0.83–0.95 460 497.93 0.92 0.84–1.01
Trachea, bronchus and 
lung (C33–C34)
1039 1376.19 0.75 0.71–0.80 530 865.12 0.61 0.56–0.67 232 478.60 0.48 0.42–0.55
Skin, malignant melanoma 
(C43)
230 257.40 0.89 0.78–1.02 188 160.19 1.17 1.01–1.35 119 91.08 1.31 1.08–1.56
Prostate (C61) 1857 1833.70 1.01 0.97–1.06 1359 1152.26 1.18 1.12–1.24 787 628.58 1.25 1.17–1.34
Testis (C62) 154 164.80 0.93 0.79–1.09 107 101.97 1.05 0.86–1.27 77 61.20 1.26 0.99–1.57
Urinary tract (C64-
C66+C68)
330 392.87 0.84 0.75–0.94 206 247.03 0.83 0.72–0.96 107 137.47 0.78 0.64–0.94
Bladder (C67, D09.0, 
D41.4)
699 718.87 0.97 0.90–1.05 470 451.25 1.04 0.95–1.14 266 246.29 1.08 0.95–1.22
NHL (C82–C85) 197 255.32 0.77 0.67–0.89 130 160.18 0.81 0.68–0.96 81 90.11 0.90 0.71–1.12
Leukaemia (C91–C95) 204 253.60 0.80 0.70–0.92 113 158.75 0.71 0.59–0.86 61 89.49 0.68 0.52–0.88
All malignancies (excluding 
C44)
7761 8751.69 0.89 0.87–0.91 5024 5493.56 0.91 0.89–0.94 2765 3041.59 0.91 0.88–0.94
† PY: Person-Years were approximated by population figures: the sum of population at the end of the year in the years under consideration.
Primary site unspecified 116 78 1.18 0.90–1.56 36 1.13 0.76–1.68
All malignancies (excluding C44) 7258 4508 1.09 1.03–1.17 2293 1.04 0.97–1.11
All malignancies (including C44) 8968 6128 1.14 1.08–1.21 3100 1.10 1.04–1.17
* Winegrowing communities with >0, <= 5% area under wine cultivation
† PY: Person-Years were approximated by population figures: the sum of population at the end of the year in the years under consideration.
‡ adjusted for age, rural or urban environment, and fruit cultivation
§ Poisson distribution of case counts assumed for: C21, C52, C55, C57, C65, C81
Table 3: Cancer risks (incidence rate ratios RR) in women with residence in communities with a large or medium area under wine 
cultivation vs. women in communities with low area under wine cultivation (Continued)Journal of Occupational Medicine and Toxicology 2008, 3:12 http://www.occup-med.com/content/3/1/12
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the Rhineland-Palatinate cancer registry would tend to
result in potentially considerable underestimation,
decreased SIR are not mentioned in the following (and
should not be interpreted). The standardized incidence
ratios of malignant melanoma remains statistically
increased in men (SIR for a medium area under cultiva-
tion = 1.17 (95% CI 1.01–1.35), SIR for a large area under
cultivation = 1.31 (95% CI 1.08–1.56)). Furthermore, the
SIR for prostate cancer remains statistically significant: the
SIR is 1.18 (95% CI 1.12–1.24) for a medium area under
cultivation and 1.25 (95% CI 1.17–1.34) for a large area
under cultivation. The increased incidence of testicular
cancer in communities with a large area under wine culti-
vation is of borderline statistical significance (SIR = 1.26;
95% CI 0.99–1.57). Among women, we find an elevated
SIR for endometrial cancer in communities with a large
area under cultivation (SIR = 1.43; 95% CI 1.20–1.68).
Breast cancer incidence is increased in communities with
a medium area under cultivation (SIR = 1.07; 95% CI
1.02–1.12), but not in communities with a large area
under cultivation (SIR = 0.99; 95% CI 0.92–1.06).
Discussion
In this ecological study, a statistically significant positive
association with the extent of viniculture is observed for
non-melanoma skin cancer in males and females, prostate
cancer, bladder cancer, and non-Hodgkin lymphoma in
males, but not in females. Lung cancer risk is significantly
reduced in communities with a large area under cultiva-
tion. Our main hypothesis that pesticides might play a
role for the observed associations will be discussed for
specific cancer types in the following.
Specific tumours
Non-melanotic skin cancer
Several studies have shown that the lifetime cumulative
sun exposure is responsible for the development of non-
melanotic skin cancer (for an overview, see [24,25]). In
ecologic studies, squamous cell carcinoma is related more
strongly to latitude or measured ultraviolet radiation than
is basal cell carcinoma. As more outdoor workers might be
occupied in regions with extensive winegrowing, our find-
ing of an increased non-melanotic skin cancer risk in
winegrowing communities appears plausible. In fact, in
communities with a large area under cultivation, 14.8 per-
cent of male skin cancer patients (C44 ICD-10) with
known occupation (as recorded in the cancer registry) had
worked as an outdoor worker (farmer, winegrower, gar-
dener, forestry worker or construction worker). In com-
munities with medium and a small area under cultivation,
this proportion is 12.2 percent and 7.5 percent, respec-
tively. Comparably, the proportion of outdoor workers
among female cancer skin cancer patients (C44 ICD-10) is
7.6 percent, 5.1 percent and 2.6 percent in communities
with a large, medium and small area under cultivation,
respectively. Previous arsenic exposure has to be consid-
ered as an alternative explanation: arsenical pesticides
were applied by Moselle wine growers [26] between 1920
and 1942. The clinical signs of arsenic exposure are arseni-
cal keratoses, which may progress to squamous cell carci-
Table 5: Cancer risks (standardized incidence ratios SIR) in women with residence in communities with planted winegrowing areas 
with the estimated incidence of cancer in the national population of Germany as reference
Area under wine cultivation > 0, ≤ 5% of 
community area (1,665,594 PY†)
Area under wine cultivation > 5, ≤ 20% of 
community area (1,039,435 PY†)
Area under wine cultivation > 20% of 
community area (612,714 PY†)
ICD-10 code Observed Expected SIR 95% CI Observed Expected SIR 95% CI Observed Expected SIR 95% CI
Head & neck (C00–C14) 123 93.17 1.32 1.10–1.58 70 57.01 1.23 0.96–1.55 41 31.13 1.32 0.95–1.79
Stomach (C16) 197 302.45 0.65 0.56–0.75 147 183.37 0.80 0.68–0.94 61 96.98 0.63 0.48–0.81
Colon, sigmoid & rectum 
(C18–C21)
1122 1529.06 0.73 0.69–0.78 733 929.83 0.79 0.73–0.85 346 491.03 0.70 0.63–0.78
Trachea, bronchus and lung 
(C33–C34)
342 429.49 0.80 0.71–0.89 168 263.51 0.64 0.54–0.74 94 142.96 0.66 0.53–0.80
Skin, malignant melanoma 
(C43)
274 314.29 0.87 0.77–0.98 212 191.68 1.11 0.96–1.27 109 107.56 1.01 0.83–1.22
Breast (C50) 2525 2332.19 1.08 1.04–1.13 1527 1429.33 1.07 1.02–1.12 779 786.82 0.99 0.92–1.06
Cervix uteri (C53) 162 239.01 0.68 0.58–0.79 97 145.48 0.67 0.54–0.81 47 83.17 0.57 0.42–0.75
Corpus uteri, (C54–C55) 382 309.64 1.23 1.11–1.36 244 190.05 1.28 1.13–1.46 146 102.37 1.43 1.20–1.68
Ovary and other 
unspecified female genital 
organs (C56–C57)
297 449.08 0.66 0.59–0.74 196 273.91 0.72 0.62–0.82 96 149.12 0.64 0.52–0.79
Urinary tract (C64-
C66+C68)
208 261.56 0.80 0.69–0.91 136 160.51 0.85 0.71–1.00 73 86.15 0.85 0.66–1.07
Bladder (C67, D09.0, 
D41.4)
251 325.54 0.77 0.68–0.87 158 200.30 0.79 0.67–0.92 85 107.82 0.79 0.63–0.97
NHL (C82–C85) 220 286.04 0.77 0.67–0.88 114 175.38 0.65 0.54–0.78 52 95.33 0.55 0.41–0.72
Leukaemia (C91–C95) 135 228.14 0.59 0.50–0.70 65 139.57 0.47 0.36–0.59 43 75.32 0.57 0.41–0.77
All malignancies (excluding 
C44)
7258 8285.78 0.88 0.86–0.90 4508 5070.41 0.89 0.86–0.92 2293 2740.00 0.84 0.80–0.87
† PY: Person-Years were approximated by population figures: the sum of population at the end of the year in the years under consideration.Journal of Occupational Medicine and Toxicology 2008, 3:12 http://www.occup-med.com/content/3/1/12
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noma or basal cell carcinoma [27]. Moreover, arsenic
seems to act as a co-carcinogen with ultraviolet radiation
[27]. As the latency period of non-melanotic skin cancer is
suspected to be very long, an excess in non-melanotic skin
cancers might therefore be partly explained by arsenic
exposure, however, this explanation appears rather specu-
lative. Moreover, risk estimators for non-melanotic skin
cancer do not markedly increase when our analysis is
restricted to persons aged 70 or more. The association
between sun exposure and melanoma of the skin seems to
be more complex: Intermittent sun exposure and sunburn
history rather than lifetime cumulative sun exposure plays
a role in the aetiology of melanoma of the skin [28,29].
This complex relationship might explain why our study
does not reveal a clearly increased melanoma incidence in
communities with a large area under wine cultivation.
Moreover, adjusting for potential confounders as, for
example, leisure time UV exposure, was not possible in
this study.
Brain cancer
While several epidemiological studies point to an
increased brain cancer risk among pesticide exposed per-
sons [13,14], few studies specifically focus on the residen-
tial population in winegrowing regions. In their
ecological study in the province of Trento, Italy, Ferrari
and Lovaste [30] find the highest incidence rates of intrac-
ranial tumours in regions of intensive fruit and wine cul-
tivation. However, the authors do not indicate the
significance level of their findings. Another ecological
study among French agricultural workers reveals a signifi-
cant association between pesticide exposure in vineyards
and brain cancer mortality [31]. The results of our ecolog-
ical study do not support an increased brain cancer risk of
residents in winegrowing regions (RR in the primary anal-
ysis for large vs. a small area under cultivation = 1.06
(95% CI 0.72–1.57) among men; RR = 1.21 (95% CI
0.79–1.86) among women).
Rectum cancer
Some previous studies point to a potentially elevated rec-
tum cancer risk [32,33], other studies find reduced color-
ectal cancer risks among farmers [34] or farm residents
[35]. Altogether, there is very little evidence to date for a
possible relationship between pesticide exposure and rec-
tum cancer. Our finding of an increased cancer incidence
of the rectosigmoid junction (but not of rectum cancer in
all) among males living in winegrowing communities
might be alternatively explained by life-style (e.g. dietary)
or medical (participation at screening) factors, by inho-
mogeneous reporting behavior, or by chance.
Non-Hodgkin lymphoma
The increased NHL incidence among male, but not
among female inhabitants of communities with a
medium or large area under wine cultivation suggests a
potential occupational rather than residential aetiology.
However, in communities with a medium or a large area
under cultivation, only two male NHL patients (=2 per-
cent of male NHL patients with known occupation, miss-
ing values 55 percent) and one female NHL patient (=1.3
percent of female NHL patients with known occupation,
missing values 44 percent) had worked as wine-growers,
making an occupational aetiology improbable.
Our finding of an increased NHL incidence among poten-
tially pesticide-exposed residents of winegrowing commu-
nities is in accordance with the literature. However, most
previous studies are related to agricultural workers in gen-
eral, not to winegrowing workers. In a large Italian multi-
center case-control study [36], orchard, vineyard, and
related tree and shrub workers appeared to be at increased
risk for hematolymphopoietic malignancies. The carcino-
genic effects of pesticides may be associated with their
genotoxicity and immunotoxicity [37-39], increased cell
proliferation [40], and association with chromosomal
aberrations [41]. Because of the lack of a positive associa-
tion between potential residential pesticide exposure and
NHL in females (actually with a significantly decreased
rate ratio for follicular NHL in winegrowing communities
with a large area under cultivation), our study does not
definitely support the hypothesis of an elevated NHL risk
among the residential population in Rhineland-Palatinate
winegrowing communities.
Bladder cancer
To date, there is inconclusive evidence for a relationship
between pesticide exposure and bladder cancer. In a retro-
spective cohort study among 32,600 employees of a lawn
care company, Zahm [42] finds a significantly increased
bladder cancer mortality. However, bladder cancer num-
bers are very small; furthermore, two of the three observed
deaths had no direct occupational contact with pesticides.
Rusiecki et al. [16] evaluate the cancer incidence in atra-
zine-exposed pesticide applicators among 53,943 partici-
pants in the Agricultural Health Study. In their study,
assessing atrazine exposure by lifetime days of exposure,
the rate ratio for bladder cancer is non-significantly ele-
vated to 3.06 (95% CI 0.86–10.81). Assessing atrazine
exposure by intensity-weighted lifetime days, the rate
ratio for bladder cancer decreases to 0.85 (95% CI 0.24–
2.94). Viel and Challier [17] analyze the mortality from
bladder cancer among French farmers. While the mortal-
ity among farmers is non-significantly lowered (standard-
ized mortality ratio = 0.96; 95% CI 0.85–1.08), there is a
significant association with exposure to pesticides in vine-
yards (risk ratio = 1.14; 95% CI 1.07–1.22). According to
the authors, these results could explain the French south-
north gradient in bladder cancer, as vineyards are mainly
located in Southern France.Journal of Occupational Medicine and Toxicology 2008, 3:12 http://www.occup-med.com/content/3/1/12
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Prostate cancer
Our finding of an increased prostate cancer risk in poten-
tially pesticide-exposed residents of winegrowing commu-
nities is in accordance with the literature. In a recently
conducted meta-analysis, van Maele-Fabry et al. [15]
include 18 epidemiological studies published between
1984 and 2004. The combined rate ratio for all studies is
1.28 (95% CI 1.05–1.58). According to the authors, no
specific pesticide or chemical class is responsible for the
increased risk; nevertheless, the strongest evidence con-
sists for phenoxy herbicides possibly in relation with
dioxin and furan contamination. Van Maele-Fabry [15]
point to the lack of fundamental understanding of the
basic biology of human prostate cancer: hormones (both
androgens and estrogens) would likely play a role in the
etiology or promotion of prostate cancer. Therefore, the
authors regard it as plausible that chemicals able to mod-
ulate steroid sex hormones as agonists, antagonists or as
mixed agonist-antagonist might contribute to the devel-
opment of prostate cancer through hormone-mediated
effects. Several pesticides might interfere with sexual hor-
mones through direct action on receptors but also
through indirect non-receptorial mechanisms.
Limitations
We applied an ecologic study design which does not allow
a differentiation between residential, occupational, and
life-style risk factors for cancer. The chief limitation of eco-
logic studies is the inability to link exposure with disease
in particular individuals. A second major limitation of
ecologic studies is the lack of ability to control for the
effects of potential confounding factors. Thus, observed
risk differences between communities with different area
under cultivation may be due not to varying levels of pes-
ticide usage, but rather to the independent effect of other
confounding variables on cancer risk. Moreover, our
"exposure" categories (small, medium, or large area under
cultivation) represent very crude indicators of the individ-
ual exposure; the actual individual exposure depends on
occupation, place of residence at the time of pesticide
spraying, wind direction etc. Furthermore, several tests
were performed, introducing a multiple comparison
problem (altogether, 270 risk ratios were calculated). In
general, our study design should therefore be regarded as
exploratory rather than hypothesis testing. Due to small
numbers, particularly for cancer cases in communities
with a large area under cultivation, the power of the study
to detect slight increases in incidence is limited. Many
other potential risk factors of occupation and lifestyle
from living in agricultural area would need to be dis-
cussed to explain the findings, but these would have to be
collected in a study using individual information. For
instance, data on socioeconomic levels or smoking preva-
lence were not available on a small scale. The use of 1996
data on agricultural characteristics might be criticised,
since a lag time of 4–7 years for cancers occurring 2000–
2003 is not plausible. It was not possible to obtain older
data, but since the political boundaries did not change
and agricultural land use stayed constant, their use seems
warranted in the current study.
The completeness of reported cancer cases is still relatively
low in Rhineland-Palatinate (about 80 percent for all can-
cers). Therefore, the calculation of standardized incidence
ratios for residents of winegrowing communities in com-
parison with the population of Rhineland-Palatinate
might at least partly reflect a higher completeness rather
than truly elevated risks. As a probably more reliable
approach of calculating cancer risks, we therefore decided
to compare the observed cancer cases in communities
with a medium or a large area under cultivation with – as
a kind of internal reference – the number of cases reported
in communities with a small area under cultivation. While
we regard the "internal" comparison of winegrowing
communities (communities with a medium or large area
versus small are under cultivation) as a more reliable
approach than the comparison with the Rhineland-Palat-
inate population, we nevertheless cannot totally exclude a
higher (or lower) completeness in communities with a
medium or large area under cultivation than in communi-
ties with a small area under cultivation.
Increased incidence of endocrine-related tumors with the 
estimated incidence of cancer in the national population 
of Germany as reference
In our primary analysis, we compared cancer rates in com-
munities with a large resp. medium area under cultivation
with cancer rates in communities with a small area under
cultivation. However, in fact even in communities with a
small area under cultivation, cancer incidence might be
elevated, potentially leading to an underestimation of the
results of our primary analysis (concerning rate ratios in
communities with medium or large area under cultiva-
tion). In a side analysis, we therefore calculated standard-
ized incidence ratios regardless of the incompleteness of
the Rhineland-Palatinate cancer. Because of the incom-
pleteness of the Rhineland-Palatinate cancer registry, the
results of the calculation of standardized incidence ratios
(SIR) tend to underestimate the true cancer risks for
incompletely recorded cancer subentities; therefore
decreased SIR should not be interpreted. If standardized
incidence ratios were calculated with the estimated inci-
dence of cancer in the national population of Germany as
reference, among men we found an elevated SIR for pros-
tate cancer and testicular cancer in communities with a
large area under wine cultivation. Among women, we
found an elevated SIR for endometrial cancer and (in
communities with a medium area under cultivation, but
not in communities with a large area under cultivation)
for breast cancer incidence. Altogether, the results of ourJournal of Occupational Medicine and Toxicology 2008, 3:12 http://www.occup-med.com/content/3/1/12
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additional SIR analysis are compatible with a potential
carcinogenic role of pesticides in the etiology of endo-
crine-related tumors of the breast, testis, prostate, and
endometrium.
Conclusion
This ecologic study is the first attempt to examine the rela-
tionship between cancer incidence and the area under
wine cultivation in Rhineland-Palatinate winegrowing
communities. The study results point to a potentially ele-
vated skin cancer risk, bladder cancer risk, and endocrine-
related (prostate, testicular, breast, and endometrium)
cancer risk of the population in communities with a large
area under wine cultivation. Mainly due to the ecologic
study design, the problem of multiple testing, and due to
the insufficient completeness of the Rhineland-Palatinate
cancer registry concerning the considered region, these
findings are not conclusive for a causal relationship. There
is a need for analytic epidemiologic studies differentiating
between environmental and occupational exposures to
further clarify the cancer risk associated with pesticide
usage in wine cultivation.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
AS conceived the study design, coordinated the study and
drafted the manuscript, GPH performed the statistical
analysis and participated in the study design and coordi-
nation, GH, AK, and IS participated in the design of the
study and helped to draft the manuscript, JK participated
in the statistical analysis and helped to draft the manu-
script, MB participated in the coordination of the study
and helped to design the study and draft the manuscript.
All authors read and approved the final manuscript.
References
1. De Roos AJ, Zahm SH, Cantor KP, Weisenburger DD, Holmes FF,
Burmeister LF, Blair A: Integrative assessment of multiple pes-
ticides as risk factors for non-Hodgkin's lymphoma among
men.  Occup Environ Med 2003, 60:E11.
2. McDuffie HH, Pahwa P, McLaughlin JR, Spinelli JJ, Fincham S, Dosman
JA, Robson D, Skinnider LF, Choi NW: Non-Hodgkin's lymphoma
and specific pesticide exposures in men: cross-Canada study
of pesticides and health.  Cancer Epidemiol Biomarkers Prev 2001,
10:1155-63.
3. Miligi L, Costantini AS, Bolejack V, Veraldi A, Benvenuti A, Nanni O,
Ramazzotti V, Tumino R, Stagnaro E, Rodella S, Fontana A, Vindigni
C, Vineis P: Non-Hodgkin's lymphoma, leukemia, and expo-
sures in agriculture: results from the Italian multicenter
case-control study.  Am J Ind Med 2003, 44:627-36.
4. Nanni O, Amadori D, Lugaresi C, Falcini F, Scarpi E, Saragoni A, Bui-
atti E: Chronic lymphocytic leukaemias and non-Hodgkin's
lymphomas by histological type in farming-animal breeding
workers: a population case-control study based on a priori
exposure matrices.  Occup Environ Med 1996, 53:652-7.
5. Zahm SH, Weisenburger DD, Babbitt PA, Saal RC, Vaught JB, Cantor
KP, Blair A: A case-control study of non-Hodgkin's lymphoma
and the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) in
eastern Nebraska.  Epidemiology 1990, 1:349-56.
6. 't Mannetje A, McLean D, Cheng S, Boffetta P, Colin D, Pearce N:
Mortality in New Zealand workers exposed to phenoxy her-
bicides and dioxins.  Occup Environ Med 2005, 62:34-40.
7. Baris D, Silverman DT, Brown LM, Swanson GM, Hayes RB, Schwartz
AG, Liff JM, Schoenberg JB, Pottern LM, Greenberg RS, Stewart PA:
Occupation, pesticide exposure and risk of multiple mye-
loma.  Scand J Work Environ Health 2004, 30:215-22.
8. Demers PA, Vaughan TL, Koepsell TD, Lyon JL, Swanson GM, Green-
berg RS, Weiss NS: A case-control study of multiple myeloma
and occupation.  Am J Ind Med 1993, 23:629-39.
9. Eriksson M, Karlsson M: Occupational and other environmental
factors and multiple myeloma: a population based case-con-
trol study.  Br J Ind Med 1992, 49:95-103.
10. Khuder SA, Mutgi AB: Meta-analyses of multiple myeloma and
farming.  Am J Ind Med 1997, 32:510-6.
11. Nanni O, Falcini F, Buiatti E, Bucchi L, Naldoni M, Serra P, Scarpi E,
Saragoni L, Amadori D: Multiple myeloma and work in agricul-
ture: results of a case-control study in Forli, Italy.  Cancer
Causes Control 1998, 9:277-83.
12. Carreon T, Butler MA, Ruder AM, Waters MA, vis-King KE, Calvert
GM, Schulte PA, Connally B, Ward EM, Sanderson WT, Heineman EF,
Mandel JS, Morton RF, Reding DJ, Rosenman KD, Talaska G, Cancer
B:  Gliomas and farm pesticide exposure in women: the
Upper Midwest Health Study.  Environ Health Perspect 2005,
113:546-51.
13. Khuder SA, Mutgi AB, Schaub EA: Meta-analyses of brain cancer
and farming.  Am J Ind Med 1998, 34:252-60.
14. Lee WJ, Colt JS, Heineman EF, McComb R, Weisenburger DD, Lijin-
sky W, Ward MH: Agricultural pesticide use and risk of glioma
in Nebraska, United States.  Occup Environ Med 2005, 62:786-92.
15. Van Maele-Fabry G, Libotte V, Willems J, Lison D: Review and
meta-analysis of risk estimates for prostate cancer in pesti-
cide manufacturing workers.   Cancer Causes Control 2006,
4():353-73.
16. Rusiecki JA, De RA, Lee WJ, Dosemeci M, Lubin JH, Hoppin JA, Blair
A, Alavanja MC: Cancer incidence among pesticide applicators
exposed to atrazine in the Agricultural Health Study.  J Natl
Cancer Inst 2004, 96:1375-82.
17. Viel JF, Challier B: Bladder cancer among French farmers: does
exposure to pesticides in vineyards play a part?  Occup Environ
Med 1995, 52:587-92.
18. Commission of the European Communities: Communication from
the Commission to the council and the European Parliament
on the implementation of the Community Strategy for
Endocrine Disrupters – a range of substances suspected of
interfering with the hormone systems of humans and wildlife
(COM (1999) 706).  Brussels: Commission of the European Com-
munities.  2001 Jun 14. Report No.: COM(2001) 262 final
19. Barlow SM: Agricultural chemicals and endocrine-mediated
chronic toxicity or carcinogenicity.  Scand J Work Environ Health
2005, 31(suppl 1):141-5.
20. De Rossi C, Bierl R, Riefstahl J: Organic pollutants in precipita-
tion: monitoring of pesticides and polycyclic aromatic hydro-
carbons in the region of Trier (Germany).  Physics and Chemistry
of the Earth 2003, 28:307-14.
21. Haberland J, Bertz J, Görsch B, Schön D: Krebsinzidenzschätzun-
gen für Deutschland mittels log-linearer Modelle.  Gesundheits-
wesen 2001, 63:556-560.
22. Haberland J, Bertz J, Görsch B, Dölle R, Kurth BM: Die zukünftige
Entwicklung des Krebsgeschehens in Deutschland.  Bundesge-
sundheitsbl – Gesundheitsforsch – Gesundheitsschutz 2006, 5:459-467.
23. SAS [computer program]: Version 9.1.3 Cary, NC: SAS Institute Inc;
2004. 
24. English DR, Armstrong BK, Kricker A, Fleming C: Sunlight and can-
cer.  Cancer Causes Control 1997, 8:271-83.
25. Ramirez CC, Federman DG, Kirsner RS: Skin cancer as an occu-
pational disease: the effect of ultraviolet and other forms of
radiation.  Int J Dermatol 2005, 44:95-100.
26. Grobe JW: [Expert-testimony and therapeutic findings and
observations in wine-dressers of the Mosel-region with late
sequelae of arsenic intoxication].  Berufsdermatosen 1977,
25:124-30.
27. Gawkrodger DJ: Occupational skin cancers.  Occup Med (Lond)
2004, 54:458-63.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Occupational Medicine and Toxicology 2008, 3:12 http://www.occup-med.com/content/3/1/12
Page 11 of 11
(page number not for citation purposes)
28. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P,
Melchi CF: Meta-analysis of risk factors for cutaneous
melanoma: II. Sun exposure.  Eur J Cancer 2005, 41:45-60.
29. Oliveria SA, Saraiya M, Geller AC, Heneghan MK, Jorgensen C: Sun
exposure and risk of melanoma.  Arch Dis Child 2006, 91:131-8.
30. Ferrari G, Lovaste MG: Primary intracranial tumors in the
province of Trento-Italy (1977–1984). Distribution by admin-
istrative units.  Neuroepidemiology 1986, 5:159-70.
31. Viel JF, Challier B, Pitard A, Pobel D: Brain cancer mortality
among French farmers: the vineyard pesticide hypothesis.
Arch Environ Health 1998, 53:65-70.
32. Lynge E: A follow-up study of cancer incidence among work-
ers in manufacture of phenoxy herbicides in Denmark.  Br J
Cancer 1985, 52:259-70.
33. Soliman AS, Smith MA, Cooper SP, Ismail K, Khaled H, Ismail S,
McPherson RS, Seifeldin IA, Bondy ML: Serum organochlorine
pesticide levels in patients with colorectal cancer in Egypt.
Arch Environ Health 1997, 52:409-15.
34. Kaerlev L, Lynge E, Sabroe S, Olsen J: Colon cancer controls ver-
sus population controls in case-control studies of occupa-
tional risk factors.  BMC Cancer 2004, 22:15.
35. Wang Y, Lewis-Michl EL, Hwang SA, Fitzgerald EF, Stark AD: Cancer
incidence among a cohort of female farm residents in New
York State.  Arch Environ Health 2002, 57:561-7.
36. Costantini AS, Miligi L, Kriebel D, Ramazzotti V, Rodella S, Scarpi E,
Stagnaro E, Tumino R, Fontana A, Masala G, Vigano C, Vindigni C,
Crosignani P, Benvenuti A, Vineis P: A multicenter case-control
study in Italy on hematolymphopoietic neoplasms and occu-
pation.  Epidemiology 2001, 12:78-87.
37. Faustini A, Settimi L, Pacifici R, Fano V, Zuccaro P, Forastiere F:
Immunological changes among farmers exposed to phenoxy
herbicides: preliminary observations.  Occup Environ Med 1996,
53:583-5.
38. Zahm SH, Ward MH, Blair A: Pesticides and cancer.  Occup Med
1997, 12:269-89.
39. Zahm SH, Blair A: Pesticides and non-Hodgkin's lymphoma.
Cancer Res 1992, 52(suppl):5485s-8s.
40. Figgs LW, Holland NT, Rothmann N, Zahm SH, Tarone RE, Hill R,
Vogt RF, Smith MT, Boysen CD, Holmes FF, VanDyck K, Blair A:
Increased lymphocyte replicative index following 2,4-dichlo-
rophenoxyacetic acid herbicide exposure.  Cancer Causes Con-
trol 2000, 11:373-80.
41. Schroeder JC, Olshan AF, Baric R, Dent GA, Weinberg CR, Yount B,
Cerhan JR, Lynch CF, Schuman LM, Tolbert PE, Rothman N, Cantor
KP, Blair A: Agricultural risk factors for t(14;18) subtypes of
non-Hodgkin's lymphoma.  Epidemiology 2001, 12:701-9.
42. Zahm SH: Mortality study of pesticide applicators and other
employees of a lawn care service company.  J Occup Environ Med
1997, 39:1055-67.